Literature DB >> 17098974

A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells.

Adrien Breiman1, Damien Vitour1, Myriam Vilasco1, Catherine Ottone1, Sonia Molina2, Lydiane Pichard2, Chantal Fournier3, David Delgrange4, Pierre Charneau5, Gilles Duverlie6, Czeslaw Wychowski4, Patrick Maurel2, Eliane F Meurs1.   

Abstract

As a tool for the identification and/or purification of hepatitis C virus (HCV)-infected cells, a chimeric form of the Gal4VP16 transcription factor was engineered to be activated only in the presence of the HCV NS3/4A protease and to induce different reporter genes [choramphenical acetyltransferase (CAT), green fluorescent protein (GFP) and the cell-surface marker H-2K(k)] through the (Gal4)(5)-E1b promoter. For this, the NS5A/5B trans-cleavage motif of HCV of genotype 1a was inserted between Gal4VP16 and the N terminus of the endoplasmic reticulum (ER)-resident protein PERK, and it was demonstrated that it could be cleaved specifically by NS3/4A. Accordingly, transient transfection in tetracycline-inducible UHCV-11 cells expressing the HCV polyprotein of genotype 1a revealed the migration of the Gal4VP16 moiety of the chimera from the ER to the nucleus upon HCV expression. Activation of the chimera provoked specific gene induction, as shown by CAT assay, first in UHCV-11 cells and then in Huh-7 cells expressing an HCV replicon of genotype 1b (Huh-7 Rep). In addition, the GFP reporter gene allowed rapid fluorescence monitoring of HCV expression in the Huh-7 Rep cells. Finally, the chimera was introduced into Huh-7.5 cells infected with cell culture-generated HCV JFH1 (genotype 2a), allowing the purification of the HCV-infected cells by immunomagnetic cell sorting using H-2K(k) as gene reporter. In conclusion, the Gal4VP16 chimera activation system can be used for the rapid identification and purification of HCV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098974     DOI: 10.1099/vir.0.82214-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

2.  Fluorescence resonance energy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells.

Authors:  Rosario Sabariegos; Fernando Picazo; Beatriz Domingo; Sandra Franco; Miguel-Angel Martinez; Juan Llopis
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

3.  A Dual-reporter system for real-time monitoring and high-throughput CRISPR/Cas9 library screening of the hepatitis C virus.

Authors:  Qingpeng Ren; Chan Li; Pengfei Yuan; Changzu Cai; Linqi Zhang; Guangxiang George Luo; Wensheng Wei
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

4.  Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.

Authors:  Ana R Ferreira; Ana C Magalhães; Fátima Camões; Ana Gouveia; Marta Vieira; Jonathan C Kagan; Daniela Ribeiro
Journal:  J Cell Mol Med       Date:  2016-02-10       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.